Advertisement

Topics

Merck Gets FDA Approval Of Prevymis For Prevention Of CMV Infection

06:57 EST 9 Nov 2017 | RTTNews

Merck & Co., Inc. (MRK), known as MSD outside the United States and Canada, said that the U.S. Food and Drug Administration has approved Prevymis or letermovir once-daily tablets for oral use and injection for intravenous infusion.

Original Article: Merck Gets FDA Approval Of Prevymis For Prevention Of CMV Infection

NEXT ARTICLE

More From BioPortfolio on "Merck Gets FDA Approval Of Prevymis For Prevention Of CMV Infection"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...